EXPANSE Trademark

Trademark Overview

On Wednesday, February 1, 2012, a trademark application was filed for EXPANSE with the United States Patent and Trademark Office. The USPTO has given the EXPANSE trademark a serial number of 85530619. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Friday, November 22, 2013. This trademark is owned by Bristol-Myers Squibb Company. The EXPANSE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Medical and scientific research, namely, providing information about clinical trials and clinical studies conducted on pharmaceutical preparations for human use
expanse

General Information

Serial Number85530619
Word MarkEXPANSE
Filing DateWednesday, February 1, 2012
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateFriday, November 22, 2013
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesMedical and scientific research, namely, providing information about clinical trials and clinical studies conducted on pharmaceutical preparations for human use

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, February 6, 2012
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBristol-Myers Squibb Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10154

Trademark Events

Event DateEvent Description
Friday, November 22, 2013ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Friday, November 22, 2013ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Friday, April 26, 2013NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, April 26, 2013NON-FINAL ACTION E-MAILED
Friday, April 26, 2013NON-FINAL ACTION WRITTEN
Thursday, April 25, 2013TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, April 24, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, April 24, 2013TEAS REQUEST FOR RECONSIDERATION RECEIVED
Tuesday, March 12, 2013TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, October 24, 2012NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, October 24, 2012FINAL REFUSAL E-MAILED
Wednesday, October 24, 2012FINAL REFUSAL WRITTEN
Friday, October 19, 2012TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, October 19, 2012CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, October 19, 2012TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, July 10, 2012ASSIGNED TO EXAMINER
Monday, May 7, 2012NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, May 7, 2012NON-FINAL ACTION E-MAILED
Monday, May 7, 2012NON-FINAL ACTION WRITTEN
Saturday, May 5, 2012ASSIGNED TO EXAMINER
Monday, February 6, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, February 4, 2012NEW APPLICATION ENTERED IN TRAM

Related Keywords

expanse clinical studies trials conducted pharmaceutical human preparations about research scientific